CD19 Knockout Raji Cell Line
CD19 Knockout Raji Cell Line by ImmunoClone facilitates efficient CAR-T cell therapy validation and B-cell receptor signaling disruption investigations.
敲除 / 敲低 / 敲入 / 过表达稳转细胞系与敲除细胞裂解物,按「基因 × 细胞系」粒度提供,支持定制建株。 共 1,221 个产品。
CD19 Knockout Raji Cell Line by ImmunoClone facilitates efficient CAR-T cell therapy validation and B-cell receptor signaling disruption investigations.
CD19 Knockout Raji/Luciferase Cell Line by ImmunoClone provides a validated model for investigating antigen escape in diffuse large B-cell lymphoma research.
CD19/CD20 Double Knockout Raji Cell Line by ImmunoClone enables precise evaluation of B-cell depletion therapies and combination immunotherapy mechanisms.
CD19/CD20 Double Knockout Raji/Luciferase Cell Line provides a validated dual-knockout model for CAR-T and bispecific antibody therapy development.
A stable monoclonal cell line expressing CD2 was constructed using lentivirus technology based on CHO-K1 cells.
CD20 Knockout Raji Cell Line by ImmunoClone is optimized for anti-CD20 drug development and B-cell signaling studies in lymphoma research applications.
CD20 Knockout Raji/Luciferase Cell Line provides a bioluminescent CD20-deficient model for evaluating CD19-targeting therapies and CAR-T cell efficacy.
A monoclonal cell line stably expressing CD200 constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing CD200R1 constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing CD200R1 constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing CD200LA constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing CD215(IL15RA) constructed using viral technology based on HEK-293 cells.
A stable monoclonal cell line expressing CD22 was constructed using lentivirus technology based on CHO-K1 cells.
A monoclonal cell line stably expressing CD226 constructed using viral technology based on CHO-K1 cells.
Stable monoclonal cell line expressing CD24 was constructed using lentivirus technology based on HEK-293 cells.
Stable monoclonal cell line expressing CD24 was established using lentivirus technology based on HEK-293 cells.
Established monoclonal cell line stably expressing CD24 based on MC38 cells using lentivirus technology.
A monoclonal cell line stably expressing CD25 constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing CD25 constructed using viral technology based on HEK293 cells.
A monoclonal cell line stably expressing PD-L1 constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing PD-L1 constructed using viral technology based on MC38 cells.
Stable monoclonal cell line expressing CD276 (B7H3) was constructed using lentivirus technology based on CHO-K1 cells.
Stable monoclonal cell line expressing CD28 was constructed using lentiviral technology based on CHO-K1 cells.
Stable monoclonal cell line expressing CD28 constructed using lentiviral technology based on HEK-293 cells.
共 1,221 个产品 | 第 4 / 51 页